Gandara, David R <br/><br/>
Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).  [electronic resource] 

 -  Clinical lung cancer  Sep 2006 
 - 116-21 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1525-7304 
<br/><br/><label>Standard No.: </label>10.3816/CLC.2006.n.039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Combined Modality Therapy<br/>Disease Progression<br/>Docetaxel<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Southwestern United States<br/>Survival Analysis<br/>Survival Rate<br/>Taxoids--adverse effects<br/>Time Factors